Medicare AdvantageCoverageMedium impact
MA06.023c, Nerve Fiber Density Testing
Independence Blue Cross·Neurology, Endocrinology, Pain Management·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.023c for Nerve Fiber Density Testing has been reissued and is now effective. This appears to be an updated version of an existing policy that may affect coverage or billing requirements for nerve fiber density testing procedures.
Action Required
By October 1, 2025: Billing team should review the complete MA06.023c policy document at the provided URL to understand specific changes to nerve fiber density testing coverage and billing requirements. Update billing procedures and staff training accordingly based on the detailed policy content.